Overview
Portfolio
More
Blueio
Boston, United States
Builds long‑term, purpose‑driven global companies solving critical problems through deep technical innovation.
Portfolio
7+
Employees
5+
Founded
2012
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 3 of 3 matched portfolio companies
The startup offers a cyber risk assessment platform that employs patented artificial intelligence, actuarial data, and financial modeling to automate compliance tasks and quantify cyber risk in financial terms. This enables organizations to prioritize cybersecurity investments and enhance their risk management strategies effectively.
Funding: $30.7M
Rough estimate of the amount of funding raised
Funding: $30.7M
Rough estimate of the amount of funding raised
GreenLight Biosciences produces RNA‑interference (RNAi) biopesticides that silence target genes in insects, fungi, and weeds, delivering species‑level specificity with rapid environmental degradation and no residue on crops. Their scalable manufacturing platform creates commercial‑grade foliar sprays compatible with standard farm equipment, offering growers a residue‑free, EPA‑approved alternative to conventional chemicals.
XaiRec provides a platform for building and deploying explainable AI recommendation systems. It focuses on transparency by offering tools to understand model predictions and feature importance in real-time. This allows businesses to deploy trustworthy, auditable personalization engines across various customer touchpoints.
Showing 4 of 4 unmatched portfolio companies